Definitive Healthcare Corp.
DH
$2.59
$0.000.00%
| Weiss Ratings | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.71 | |||
| Price History | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.50% | |||
| 30-Day Total Return | -47.36% | |||
| 60-Day Total Return | -42.32% | |||
| 90-Day Total Return | -37.59% | |||
| Year to Date Total Return | -37.14% | |||
| 1-Year Total Return | -67.99% | |||
| 2-Year Total Return | -78.22% | |||
| 3-Year Total Return | -86.02% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -68.98% | |||
| 52-Week Low % Change | 1.77% | |||
| Price | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.35 | |||
| 52-Week Low Price | $2.55 | |||
| 52-Week Low Price (Date) | Mar 13, 2025 | |||
| 52-Week High Price (Date) | Apr 01, 2024 | |||
| Valuation | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 292.44M | |||
| Enterprise Value | 417.49M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.53 | |||
| Earnings Per Share Growth | 99.23% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.18 | |||
| Price/Book (Q) | 0.66 | |||
| Enterprise Value/Revenue (TTM) | 1.66 | |||
| Price | $2.59 | |||
| Enterprise Value/EBITDA (TTM) | 9.93 | |||
| Enterprise Value/EBIT | -43.30 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 115.02M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 508 720 4224 | |||
| Address | 492 Old Connecticut Path Framingham, MA 01701 | |||
| Website | www.definitivehc.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -3.82% | |||
| Profit Margin | -163.80% | |||
| Management Effectiveness | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.41% | |||
| Return on Equity | -- | |||
| Income Statement | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 252.20M | |||
| Total Revenue (TTM) | 252.20M | |||
| Revenue Per Share | $2.19 | |||
| Gross Profit (TTM) | 211.52M | |||
| EBITDA (TTM) | 42.03M | |||
| EBIT (TTM) | -9.64M | |||
| Net Income (TTM) | -413.12M | |||
| Net Income Avl. to Common (TTM) | -413.12M | |||
| Total Revenue Growth (Q YOY) | -5.53% | |||
| Earnings Growth (Q YOY) | -534.01% | |||
| EPS Diluted (TTM) | -3.53 | |||
| EPS Diluted Growth (Q YOY) | -484.30% | |||
| Balance Sheet | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 290.88M | |||
| Cash Per Share (Q) | $2.53 | |||
| Total Current Assets (Q) | 370.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 607.19M | |||
| Current Ratio (Q) | 2.297 | |||
| Book Value Per Share (Q) | $3.90 | |||
| Total Assets (Q) | 1.09B | |||
| Total Current Liabilities (Q) | 161.16M | |||
| Total Debt (Q) | 253.11M | |||
| Total Liabilities (Q) | 482.20M | |||
| Total Common Equity (Q) | 444.38M | |||
| Cash Flow | DH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -26.41M | |||
| Cash from Financing (TTM) | -56.75M | |||
| Net Change in Cash (TTM) | -25.60M | |||
| Levered Free Cash Flow (TTM) | 71.70M | |||
| Cash from Operations (TTM) | 58.20M | |||
